Bipartisan Resolution Urges Creation of International Gene-Editing Standards
By Samara Rosenfeld,
Inside Digital Health [cites CGS' Marcy Darnovsky]
| 07. 19. 2019
It’s no secret that gene editing has sparked ethical concerns. In March, scientists and ethicists from seven countries issued a strict global moratorium on heritable genome editing in sperm, eggs and embryos. And this week, Sens. Dianne Feinstein, Marco Rubio and Jack Reed introduced a bipartisan resolution urging for the creation of international ethical standards for gene-editing research.
“There has been global outcry in response to unethical gene-editing experiments, and scientists have warned of the potential long-term consequences that could impact generations,” said Rubio, a Republican from Florida. “As we move forward, it’s vital that the U.S. lead the way in creating ethical standards for gene-editing research.”
The news of the resolution follows reports from last November of Chinese researchers claiming to have used CRISPR gene-editing technology to help a couple give birth to genetically modified twin girls. While this news raised many eyebrows, it did not stop a Russian scientist from saying this past June that he was planning to produce gene-edited babies in HIV-positive women.
The resolution states that the Senate opposes the...
Related Articles
By Katie Hunt, CNN | 07.30.2025
Scientists are exploring ways to mimic the origins of human life without two fundamental components: sperm and egg.
They are coaxing clusters of stem cells – programmable cells that can transform into many different specialized cell types – to form...
By Ewen Callaway, Nature | 08.04.2025
For months, researchers in a laboratory in Dallas, Texas, worked in secrecy, culturing grey-wolf blood cells and altering the DNA within. The scientists then plucked nuclei from these gene-edited cells and injected them into egg cells from a domestic dog ...
By Kristel Tjandra, Genetic Engineering & Biotechnology News | 07.30.2025
CRISPR has taken the bioengineering world by storm since its first introduction. From treating sickle cell diseases to creating disease-resistant crops, the technology continues to boast success on various fronts. But getting CRISPR experiments right in the lab isn’t simple...
By Arthur Caplan and James Tabery, Scientific American | 07.28.2025
An understandable ethics outcry greeted the June announcement of a software platform that offers aspiring parents “genetic optimization” of their embryos. Touted by Nucleus Genomics’ CEO Kian Sadeghi, the $5,999 service, dubbed “Nucleus Embryo,” promised optimization of...